A review of the sonographic assessment of tumor metastases in liver and superficial lymph nodes

Veterinary Radiology and Ultrasound

Volumn 45, Issue 5, 2004, Pages 438-448

  Nyman, Helena T ^a   Kristensen, Annemarie T ^a   Flagstad, Annette ^a   McEvoy, Fintan J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Contrast enhanced ultrasonography; Doppler; Liver; Lymph node; Metastases

Indexed keywords

CONTRAST MEDIUM;

BLOOD VESSEL; CALCULATION; CANCER DIAGNOSIS; CARCINOGENESIS; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; ECHOGRAPHY; HUMAN; LIVER ANGIOGRAPHY; LIVER METASTASIS; LYMPH NODE; NONHUMAN; REVIEW;

ANIMALS; CONTRAST MEDIA; DOG DISEASES; DOGS; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 7244243776     PISSN: 10588183     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1740-8261.2004.04077.x     Document Type: Review

References (148)

1. Pugh CR. Ultrasonographic examination of abdominal lymph nodes in the dog. Vet Radiol Ultrasound 1994;35:110-115.
2. Gaschen L, Kircher P, Hoffmann G, et al. Endoscopic ultrasonography for the diagnosis of intrathoracic lesions in two dogs. Vet Radiol Ultrasound 2003;44:292-299.
3. St Vincent RS, Pharr JW. Transesophageal ultrasonography of the normal canine mediastinum. Vet Radiol Ultrasound 1998;39:197-205.
4. Mahfouz AE, Hamm B, Mathieu D. Imaging of metastases to the liver. Eur Radiol 1996;6:607-614.
5. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
6. Cosgrove DO, Bamber JC, Davey JB, McKinna JA, Sinnett HD. Color Doppler signals from breast tumors. Work in progress. Radiology 1990;176:175-180.
7. Madjar H, Prompeler HJ, Sauerbrei W, Wolfarth R, Pfleiderer A. Color Doppler flow criteria of breast lesions. Ultrasound Med Biol 1994;20:849-858.
8. Dock W, Grabenwoger F, Metz V, Eibenberger K, Farres MT. Tumor vascularization: assessment with duplex sonography. Radiology 1991;181:241-244.
9. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med 1973;138:745-753.
10. Gammill SL, Shipkey FH, Himmelfarb EH, Parvey LS, Rabinowitz JG. Roentgenology-pathology correlative study of neovascularity. Am J Roentgenol 1976;126:376-385.
11. Kan Z, Ivancev K, Lunderquist A, et al. In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology 1993;187:621-626.
12. Ney FG, Feist JH, Altemus LR, Ordinario VR. The characteristic angiographic criteria of malignancy. Radiology 1972;104:567-570.
13. Ramos IM, Taylor KJ, Kier R, Burns PN, Snower DP, Carter D. Tumor vascular signals in renal masses: detection with Doppler US. Radiology 1988;168:633-637.
14. Schoenberger SG, Sutherland CM, Robinson AE. Breast neoplasms: duplex sonographic imaging as an adjunct in diagnosis. Radiology 1988;168:665-668.
15. Shubik P. Vascularization of tumors: a review. J Cancer Res Clin Oncol 1982;103:211-226.
16. Strickland B. The value of arteriography in the diagnosis of bone tumours. Br J Radiol 1959;32:705-713.
17. Taylor KJ, Ramos I, Morse SS, Fortune KL, Hammers L, Taylor CR. Focal liver masses: differential diagnosis with pulsed Doppler US. Radiology 1987;164:643-647.
18. Taylor KJ, Ramos I, Carter D, Morse SS, Snower D, Fortune K. Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology 1988;166:57-62.
19. Viamonte M Jr., Roen S, LePage J. Nonspecificity of abnormal vascularity in the angiographic diagnosis of malignant neoplasms. Radiology 1973;106:59-63.
20. Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
21. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med 1971;133:275-288.
22. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
23. Schor AM, Schor SL. Tumour angiogenesis. J Pathol 1983;141:385-413.
24. Cosgrove D. Microbubble enhancement of tumour neovascularity. Eur Radiol 1999;9(Suppl 3):S413-S414.
25. McEvoy FJ, Edgell TA, Webbon PM, Gaffney PJ. Detection of fibrin in canine neoplasia. Br Vet J 1996;152:83-91.
26. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-3340.
27. Hata T, Hata K, Senoh D, et al. Doppler ultrasound assessment of tumor vascularity in gynecologic disorders. J Ultrasound Med 1989;8:309-314.
28. Kier R, Taylor KJ, Feyock AL, Ramos IM. Renal masses: characterization with Doppler US. Radiology 1990;176:703-707.
29. Kuijpers D, Jaspers R. Renal masses: differential diagnosis with pulsed Doppler US. Radiology 1989;170:59-60.
30. Ohnishi K, Nomura F. Ultrasonic Doppler studies of hepatocellular carcinoma and comparison with other hepatic focal lesions. Gastroenterology 1989;97:1489-1497.
31. Shimamoto K, Sakuma S, Ishigaki T, Ishiguchi T, Itoh S, Fukatsu H. Hepatocellular carcinoma: evaluation with color Doppler US and MR imaging. Radiology 1992;182:149-153.
32. Tanaka S, Kitamra T, Fujita M, Kasugai H, Inoue A, Ishiguro S. Small hepatocellular carcinoma: differentiation from adenomatous hyperplastic nodule with color Doppler flow imaging. Radiology 1992;182:161-165.
33. Chang DB, Yuan A, Yu CJ, Luh KT, Kuo SH, Yang PC. Differentiation of benign and malignant cervical lymph nodes with color Doppler sonography. Am J Roentgenol 1994;162:965-968.
34. Ramos I, Fernandez LA, Morse SS, Fortune KL, Taylor KJ. Detection of neovascular signals in a 3 day Walker 256 rat carcinoma by CW Doppler ultrasound. Ultrasound Med Biol 1988;14:123-126.
35. Burns PN, Gowland MR, Rimmer S. Use of Doppler ultrasound in the detection of changes in the blood flow in tumour circulation in the rabbit. J Physiol 1983;342:12-13.
36. Cosgrove DO, Kedar RP, Bamber JC, et al. Breast diseases: color Doppler US in differential diagnosis. Radiology 1993;189:99-104.
37. Dixon JM, Walsh J, Paterson D, Chetty U. Colour Doppler ultrasonography studies of benign and malignant breast lesions. Br J Surg 1992;79:259-260.
38. Lee CN, Cheng WF, Chen CA, Chu JS, Hsieh CY, Hsieh FJ. Angiogenesis of endometrial carcinomas assessed by measurement of intratumoral blood flow, microvessel density, and vascular endothelial growth factor levels. Obstet Gynecol 2000;96:615-621.
39. Fleischer AC, Wojcicki WE, Donnelly EF, et al. Quantified color Doppler sonography of tumor vascularity in an animal model. J Ultrasound Med 1999;18:547-551.
40. Donnelly EF, Geng L, Wojcicki WE, Fleischer AC, Hallahan DE. Quantified power Doppler US of tumor blood flow correlates with micro-scopic quantification of tumor blood vessels. Radiology 2001;219:166-170.
41. Dragoni F, Cartoni C, Pescarmona E, et al. The role of high resolution pulsed and color Doppler ultrasound in the differential diagnosis of benign and malignant lymphadenopathy: results of multivariate analysis. Cancer 1999;85:2485-2490.
42. Marchal G, Oyen R, Verschakelen J, Gelin J, Baert AL, Stessens RC. Sonographic appearance of normal lymph nodes. J Ultrasound Med 1985;4:417-419.
43. Na DG, Lim HK, Byun HS, Kim HD, Ko YH, Baek JH. Differential diagnosis of cervical lymphadenopathy: usefulness of color Doppler sonography. Am J Roentgenol 1997;168:1311-1316.
44. Rubaltelli L, Proto E, Salmaso R, Bortoletto P, Candiani F, Cagol P. Sonography of abnormal lymph nodes in vitro: correlation of sonographic and histologic findings. Am J Roentgenol 1990;155:1241-1244.
45. Steinkamp HJ, Mueffelmann M, Bock JC, Thiel T, Kenzel P, Felix R. Differential diagnosis of lymph node lesions: a semiquantitative approach with colour Doppler ultrasound. Br J Radiol 1998;71:828-833.
46. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 1992;183:215-220.
47. Wu CH, Chang YL, Hsu WC, Ko JY, Sheen TS, Hsieh FJ. Usefulness of Doppler spectral analysis and power Doppler sonography in the differentiation of cervical lymphadenopathies. Am J Roentgenol 1998;171:503-509.
48. Wu CH, Shih JC, Chang YL, Lee SY, Hsieh FJ. Two-dimensional and three-dimensional power Doppler sonographic classification of vascular patterns in cervical lymphadenopathies. J Ultrasound Med 1998;17:459-464.
49. Choi MY, Lee JW, Jang KJ. Distinction between benign and malignant causes of cervical, axillary, and inguinal lymphadenopathy: value of Doppler spectral waveform analysis. Am J Roentgenol 1995;165:981-984.
50. Mountford RA, Atkinson P. Doppler ultrasound examination of pathologically enlarged lymph nodes. Br J Radiol 1979;52:464-467.
51. Tohnosu N, Onoda S, Isono K. Ultrasonographic evaluation of cervical lymph node metastases in esophageal cancer with special reference to the relationship between the short to long axis ratio (S/L) and the cancer content. J Clin Ultrasound 1989;17:101-106.
52. Sakai F, Kiyono K, Sone S, et al. Ultrasonic evaluation of cervical metastatic lymphadenopathy. J Ultrasound Med 1988;7:305-310.
53. Shozushima M, Suzuki M, Nakasima T, Yanagisawa Y, Sakamaki K, Takeda Y. Ultrasound diagnosis of lymph node metastasis in head and neck cancer. Dentomaxillofac Radiol 1990;19:165-170.
54. Ahuja A, Ying M, Evans R, King W, Metreweli C. The application of ultrasound criteria for malignancy in differentiating tuberculous cervical adenitis from metastatic nasopharyngeal carcinoma. Clin Radiol 1995;50:391-395.
55. Ishii J, Amagasa T, Tachibana T, Shinozuka K, Shioda S. Ultrasonic evaluation of cervical lymph node metastasis of squamous cell carcinoma in oral cavity. Bull Tokyo Med Dent Univ 1989;36:63-67.
56. Vassallo P, Edel G, Roos N, Naguib A, Peters PE. In-vitro high-resolution ultrasonography of benign and malignant lymph nodes. A sonographic-pathologic correlation. Invest Radiol 1993;28:698-705.
57. Solbiati L, Cioffi V, Ballarati E. Ultrasonography of the neck. Radiol Clin North Am 1992;30:941-954.
58. van den Brekel MW, Stel HV, Castelijns JA, Nauta JJ, van dWI, Valk J, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379-384.
59. Solbiati L, Rizzatto G, Bellotti E, et al. High-resolution sonography of cervical lymph nodes in head and neck cancer: criteria for differentiation of reactive versus malignant nodes. Radiology 1988;169:113.
60. Ahuja A, Ying M. Grey-scale sonography in assessment of cervical lymphadenopathy: review of sonographic appearances and features that may help a beginner. Br J Oral Maxillofac Surg 2000;38:451-459.
61. Chang DB, Yang PC, Luh KT, et al. Ultrasonic evaluation of cervical lymphadenopathy. J Formos Med Assoc 1990;89:286-292.
62. Smeets AJ, Zonderland HM, van d, V, Lameris JS. Evaluation of abdominal lymph nodes by ultrasound. J Ultrasound Med 1990;9:325-331.
63. Bruneton JN, Roux P, Caramella E, Demard F, Vallicioni J, Chauvel P. Ear, nose, and throat cancer: ultrasound diagnosis of metastasis to cervical lymph nodes. Radiology 1984;152:771-773.
64. Lee N, Inoue K, Yamamoto R, Kinoshita H. Patterns of internal echoes in lymph nodes in the diagnosis of lung cancer metastasis. World J Surg 1992;16:986-993.
65. Hawes RH, Gress F, Kesler KA, Cummings OW, Conces DJ, Jr. Endoscopie ultrasound versus computed tomography in the evaluation of the mediastinum in patients with non-small-cell lung cancer. Endoscopy 1994;26:784-787.
66. Kobayashi H, Danbara T, Tamaki S, et al. Detection of the mediastinal lymph nodes metastasis in lung cancer by endoscopic ultrasonography. Jpn J Med 1988;27:17-22.
67. Gorman B, Charboneau JW, James EM, et al. Medullary-thyroid carcinoma: role of high-resolution US. Radiology 1987;162:147-150.
68. Hajek PC, Salomonowitz E, Turk R, Tscholakoff D, Kumpan W, Czembirek H. Lymph nodes of the neck: evaluation with US. Radiology 1986;158:739-742.
69. Steinkamp HJ, Maurer J, Cornehl M, Knobber D, Hettwer H, Felix R. Recurrent cervical lymphadenopathy: differential diagnosis with color-duplex sonography. Eur Arch Otorhinolaryngol 251:404-409.
70. Ahuja A, Ying M, King A, Yuen HY. Lymph node hilus: gray scale and power Doppler sonography of cervical nodes. J Ultrasound Med 2001;20:987-992.
71. Ahuja A, Ying M, Yuen YH, Metreweli C. Power Doppler sonography to differentiate tuberculous cervical lymphadenopathy from nasopharyngeal carcinoma. Am J Neuroradiol 2001;22:735-740.
72. Ariji Y, Kimura Y, Hayashi N, et al. Power Doppler sonography of cervical lymph nodes in patients with head and neck cancer. Am J Neuroradiol 1998;19:303-307.
73. Giovagnorio F, Caiazzo R, Avitto A. Evaluation of vascular patterns of cervical lymph nodes with power Doppler sonography. J Clin Ultrasound 1997;25:71-76.
74. Ying M, Ahuja A, Brook F, Metreweli C. Power Doppler sonography of normal cervical lymph nodes. J Ultrasound Med 2000;19:511-517.
75. Ying M, Ahuja A, Brook F, Metreweli C. Vascularity and greyscale sonographic features of normal cervical lymph nodes: variations with nodal size. Clin Radiol 2001;56:416-419.
76. Moehrle M, Blum A, Rassner G, Juenger M. Lymph node metastases of cutaneous melanoma: diagnosis by B-scan and color Doppler sonography. J Am Acad Dermatol 1999;41:703-709.
77. Wu CH, Hsu MM, Chang YL, Hsieh FJ. Vascular pathology of malignant cervical lymphadenopathy: qualitative and quantitative assessment with power Doppler ultrasound. Cancer 1998;83:1189-1196.
78. McNicholas MM, Mercer PM, Miller JC, McDermott EW, O'Higgins NJ, MacErlean DP. Color Doppler sonography in the evaluation of palpable breast masses. Am J Roentgenol 1993;161:765-771.
79. Nyman H, Kristensen AT, Flagstad A, McEvoy FJ. Characterization of lymph nodes using ultrasonography. Proceedings of the European Association of Veterinary Diagnostic Imaging (British and Irish Division) 10-11 October, Cambridge, 2000.
80. Chaudhuri TK, Fink S. Physiological considerations in imaging liver metastases from colorectal carcinoma. Am J Physiol Imaging 1991;6:150-160.
81. Katz ML, Bergman EN. Simultaneous measurements of hepatic and portal venous blood flow in the sheep and dog. Am J Physiol 1969;216:946-952.
82. Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 1969;66:1067-1072.
83. Ackerman NB. Experimental studies on the circulation dynamics of intrahepatic tumor blood supply. Cancer 1972;29:435-439.
84. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974;75:589-596.
85. Kido C. Hepatic angiography of experimental transplantable tumor. Invest Radiol 1970;5:341-347.
86. Lien WM, Ackerman NB. The blood supply of experimental liver metastases. II. A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 1970;68:334-340.
87. Nilsson LA, Zettergren L. Effect of hepatic artery ligation on induced primary liver carcinoma in rats. Preliminary report. Acta Pathol Microbiol Scand 1967;71:187-193.
88. Rogers W, Edlich RF, Lewis DV, Aust JB. Tumor blood flow: I. Blood flow in transplantable tumors during growth. Surg Clin North Am 1967;47:1473-1482.
89. Ekelund L, Lin G, Jeppsson B. Blood-supply of experimental liver-tumors after intraarterial embolization with gelfoam powder and absolute ethanol. Cardiovasc Intervent Radiol 1984;7:234-239.
90. Haugeberg G, Strohmeyer T, Lierse W, Bocker W. The vascularization of liver metastases. Histological investigation of gelatine-injected liver specimens with special regard to the vascularization of micrometastases. J Cancer Res Clin Oncol 1988;114:415-419.
91. Lin G, Hagerstrand I, Lunderquist A. Portal blood supply of liver metastases. Am J Roentgenol 1984;143:53-55.
92. Lin G, Boijsen E, Hagerstrand I, Lunderquist A. Microvasculature architecture of small liver metastases in man: a correlation between microfil vascular preparations and histologic sections. Invest Radiol 1984;19:296-302.
93. Dingemans KP. B-16 metastases in mouse-liver and lung. 2. Morphology. Invasion Metastasis 1988;8:87-102.
94. Sakurai M, Okamura J, Kuroda C. Transcatheter chemo-embolization effective for treating hepatocellular-carcinoma: a histopathologic study. Cancer 1984;54:387-392.
95. Carlsson G, Ekelund L, Stigsson L, Hafstrom L. Vascularization and tumour volume estimations of solitary liver tumours in rats. Ann Chir Gynaecol 1983;72:187-191.
96. Healey JE. Vascular patterns in human metastatic liver tumors. 1965;120:1187.
97. Suzuki T, Sarumaru S, Kawabe K, Honjo I. Study of vascularity of tumors of the liver. Surg Gynecol Obstet 1972;134:27-34.
98. Taylor I, Bennett R, Sherriff S. The blood supply of colorectal liver metastases. Br J Cancer 1978;38:749-756.
99. Okuda K, Musha H, Yoshida T, Kanda Y, Yamazaki T. Demonstration of growing casts of hepatocellular carcinoma in the portal vein by celiac angiography: the thread and streaks sign. Radiology 1975;117:303-309.
100. Okuda K, Musha H, Yamasaki T, et al. Angiographic demonstration of intrahepatic arterio-portal anastomoses in hepatocellular carcinoma. Radiology 1977;122:53-58.
101. Witte CL, Tobin GR, Clark DS, Witte MH. Relationship of splanchnic blood flow and portal venous resistance to elevated portal pressure in the dog. Gut 1976;17:122-126.
102. Leveson SH, Wiggins PA, Giles GR, Parkin A, Robinson PJ. Deranged liver blood flow patterns in the detection of liver metastases. Br J Surg 1985;72:128-130.
103. Leen E, Goldberg JA, Anderson JR, et al. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993;34:554-557.
104. Leen E, Goldberg JA, Robertson J, Sutherland GR, McArdle CS. The use of duplex sonography in the detection of colorectal hepatic metastases. Br J Cancer 1991;63:323-325.
105. Leen E, Goldberg JA, Robertson J, et al. Detection of hepatic metastases using duplex/color Doppler sonography. Ann Surg 1991;214:599-604.
106. Nott DM, Grime SJ, Yates J, et al. Changes in the hepatic perfusion index during the development of experimental hepatic tumours. Br J Surg 1989;76:259-263.
107. Hemingway DM, Cooke TG, Grime SJ, Nott DM, Jenkins SA. Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats. Br J Surg 1991;78:326-330.
108. Fowler RC, Harris KM, Swift SE, Ward M, Greenwood DC. Hepatic Doppler perfusion index: measurement in nine healthy volunteers. Radiology 1998;209:867-871.
109. Blomley MJ, Albrecht T, Cosgrove DO, et al. Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology 1998;209:862-866.
110. Yasuhara K, Kimura K, Ohto M, et al. Pulsed Doppler in the diagnosis of small liver tumours. Br J Radiol 1988;61:898-902.
111. Merritt CR. Doppler color flow imaging. J Clin Ultrasound 1987;15:591-597.
112. Tanaka S, Kitamura T, Fujita M, Nakanishi K, Okuda S. Color Doppler flow imaging of liver tumors. Am J Roentgenol 1990;154:509-514.
113. Moriyasu F, Ban N, Nishida O, et al. Clinical application of an ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound 1986;14:579-588.
114. Nakamura T, Moriyasu F, Ban N, et al. Quantitative measurement of abdominal arterial blood flow using image-directed Doppler ultrasonography: superior mesenteric, splenic, and common hepatic arterial blood flow in normal adults. J Clin Ultrasound 1989;17:261-268.
115. Robertson J, Leen E, Goldberg JA, Angerson WJ, Sutherland GR, McArdle CS. Flow measurement using duplex Doppler ultrasound: haemodynamic changes in patients with colorectal liver metastases. Clin Phys Physiol Meas 1992;13:299-310.
116. Cuccovillo A, Lamb CR. Cellular features of sonographic target lesions of the liver and spleen in 21 dogs and a cat. Vet Radiol Ultrasound 2002;43:275-278.
117. Feeney DA, Johnston GR, Hardy RM. Two-dimensional, grayscale ultrasonography for assessment of hepatic and splenic neoplasia in the dog and cat. J Am Vet Med Assoc 1984;184:68-81.
118. Nyland TG. Ultrasonic patterns of canine hepatic lymphosarcoma. Vet Radiol Ultrasound 1984;25:167-172.
119. Carter R, Hemingway D, Cooke TG, et al. A prospective study of six methods for detection of hepatic colorectal metastases. Ann R Coll Surg Engl 1996;78:27-30.
120. Choi BI, Park JH, Kim BH, Kim SH, Han MC, Kim CW. Small hepatocellular carcinoma: detection with sonography, computed tomography (CT), angiography and Lipiodol-CT. Br J Radiol 1989;62:897-903.
121. Sheu JC, Sung JL, Chen DS, et al. Ultrasonography of small hepatic tumors using high-resolution linear-array real-time instruments. Radiology 1984;150:797-802.
122. Albrecht T, Hoffmann CW, Schmitz SA, et al. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. Am J Roentgenol 2001;176:1191-1198.
123. Bernatik T, Strobel D, Hahn EG, Becker D. Detection of liver metastases: comparison of contrast-enhanced wide-band harmonic imaging with conventional ultrasonography. J Ultrasound Med 2001;20:509-515.
124. Ohlsson B, Tranberg KG, Lundstedt C, Ekberg H, Hederstrom E. Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg 1993;159:275-281.
125. Wernecke K, Rummeny E, Bongartz G, et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. Am J Roentgenol 1991;157:731-739.
126. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. Am J Roentgenol 1990;155:49-54.
127. Forsberg F, Liu JB, Merton DA, Rawool NM, Goldberg BB. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med 1995;14:949-957.
128. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-366.
129. Mattrey RF, Wrigley R, Steinbach GC, Schutt EG, Evitts DP. Gas emulsions as ultrasound contrast agents: preliminary-results in rabbits and dogs. Invest Radiol 1994;29:S139-S141.
130. Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989;15:319-333.
131. Schneider M, Broillet A, Bussat P, Ventrone R. The use of polymeric microballoons as ultrasound contrast agents for liver imaging. Invest Radiol 1994;29:S149-S151.
132. Sehgal CM, Arger PH, Pugh CR. Sonographic enhancement of renal-cortex by contrast-media. J Ultrasound Med 1995;14:741-748.
133. Leen E. Ultrasound contrast harmonic imaging of abdominal organs. Semin Ultrasound CT MR 2001;22:11-24.
134. Mattrey RF, Kono Y. Contrast-specific imaging and potential vascular applications. Eur Radiol 1999;9(Suppl 3):S353-S358.
135. Burns PN, Powers JE, Hope Simpson D, Uhlendorf V, Fritzsch T. Harmonic imaging: principles and preliminary results. Angiology 1996;63-73.
136. Schneider M, Arditi M, Barrau MB, et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995;30:451-457.
137. Rizzatto G, Martegani A, Chersevani R, et al. Importance of staging of breast cancer and role of contrast ultrasound. Eur Radiol 2001;11(Suppl 3):E47-E51.
138. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001;11(Suppl3):E15-E26.
139. Burns PN. Harminic mode. Adv Echo-Contrast 1995;51-52.
140. Burns PN, Hope SD, Averkiou MA. Nonlinear imaging. Ultrasound Med Biol 2000;26(Suppl 1):S19-S22.
141. Leen E. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Eur Radiol 2001;11(Suppl 3):E27-E34.
142. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216:411-417.
143. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000;215:153-161.
144. Angeli E, Carpanelli R, Crespi G, Zanello A, Sironi S, Del Maschio A. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization. Radiol Med (Torino) 1994;87:24-31.
145. Maresca G, Barbara B, Summaria V, et al. Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions. The SH U 508 A (Levovist) experience. Radiol Med (Torino) 1994;87:41-49.
146. Tanaka S, Kitamra T, Yoshioka F, et al. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol 1995;21:157-160.
147. Tano S, Ueno N, Tomiyama T, Kimura K. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study. Clin Radiol 1997;52:41-45.
148. Yang WT, Metreweli C, Lam PK, Chang J. Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced color power Doppler US. Radiology 2001;220:795-802.